Femasys (FEMY) EPS (Diluted) Growth (1y) (2021 - 2025)
Femasys (FEMY) EPS (Diluted) Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 26.30% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -287.29% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 10.35% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 18.60% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -191.42% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -90.55% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 24.34% |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 24.70% |
| Mar 31, 2025 | -41.85% |
| Dec 31, 2024 | 19.74% |
| Sep 30, 2024 | 8.13% |
| Jun 30, 2024 | 4.48% |
| Mar 31, 2024 | 33.39% |
| Dec 31, 2023 | -17.03% |
| Sep 30, 2023 | -4.88% |
| Jun 30, 2023 | 1.00% |
| Mar 31, 2023 | -1.61% |
| Dec 31, 2022 | 30.47% |
| Sep 30, 2022 | -31.85% |
| Jun 30, 2022 | 57.25% |
| Mar 31, 2022 | 86.72% |
| Dec 31, 2021 | 79.62% |
| Sep 30, 2021 | 88.33% |
| Jun 30, 2021 | 66.46% |